Perivascular cells and tissue engineering: Current applications and untapped potential. (2017)
Attributed to:
In vitro and in vivo preclinical testing of pericyte-engineered grafts for correction of congenital heart defects
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.pharmthera.2016.11.002
PubMed Identifier: 27889329
Publication URI: http://europepmc.org/abstract/MED/27889329
Type: Journal Article/Review
Volume: 171
Parent Publication: Pharmacology & therapeutics
ISSN: 0163-7258